Literature DB >> 1659416

Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships.

T H Lee1, P Lympany, A E Crea, B W Spur.   

Abstract

Lipoxins are trihydroxytetraene metabolites which are derived from arachidonic acid through an interaction between different lipoxygenase pathways. Previous work has shown that lipoxin A4 (LXA4) inhibits the chemotactic responsiveness of neutrophils (PMN) to leukotriene B4. We have now assessed the structural determinants of the lipoxin A4 molecule which are necessary for its inhibitory activity, using structural analogs of LXA4 prepared by chemical synthesis. Our results indicate the importance of two adjacent free hydroxyl groups in either the R or the S configuration; one hydroxyl group has to be in the C-6 position, but the other hydroxyl group can be in either the C-5 or the C-7 position for the conferment of inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659416     DOI: 10.1016/s0006-291x(05)81354-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Paradigm shift in the pharmacological management of periodontal diseases.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Stimulation of protein kinase C redistribution and inhibition of leukotriene B4-induced inositol 1,4,5-trisphosphate generation in human neutrophils by lipoxin A4.

Authors:  K O Chung-a-on; O Soyombo; B W Spur; T H Lee
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 3.  Lipoxin A4: a novel anti-inflammatory molecule?

Authors:  T H Lee
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

Review 4.  The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function.

Authors:  D J Conrad
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

5.  Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.

Authors:  S P Colgan; C N Serhan; C A Parkos; C Delp-Archer; J L Madara
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 6.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

Review 7.  Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.

Authors:  Carmel B Nanthakumar; Richard J D Hatley; Seble Lemma; Jack Gauldie; Richard P Marshall; Simon J F Macdonald
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

8.  Leukotriene B4 in cows with normal calving, and in cows with retained fetal membranes and/or uterine subinvolution.

Authors:  H Slama; D Vaillancourt; A K Goff
Journal:  Can J Vet Res       Date:  1993-10       Impact factor: 1.310

9.  BML-11, a lipoxin receptor agonist, protected carbon tetrachloride-induced hepatic fibrosis in rats.

Authors:  Xiao-Yan Zhou; Zhong-Jian Yu; Dan Yan; Hong-Mei Wang; Yong-Hong Huang; Juan Sha; Fang-Yun Xu; Zhen-Yu Cai; Wei-Ping Min
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

10.  Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes.

Authors:  Xia Kong; Sheng-Hua Wu; Li Zhang; Xiao-Qing Chen
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.